119 related articles for article (PubMed ID: 31592983)
1. Breast Cancer Population Screening Program Results in Early Detection and Reduced Treatment and Health Care Costs for Medicaid.
Homan SG; Yun S; Bouras A; Schmaltz C; Gwanfogbe P; Lucht J
J Public Health Manag Pract; 2021; 27(1):70-79. PubMed ID: 31592983
[TBL] [Abstract][Full Text] [Related]
2. Cost of cervical cancer treatment: implications for providing coverage to low-income women under the Medicaid expansion for cancer care.
Subramanian S; Trogdon J; Ekwueme DU; Gardner JG; Whitmire JT; Rao C
Womens Health Issues; 2010; 20(6):400-5. PubMed ID: 21050999
[TBL] [Abstract][Full Text] [Related]
3. Medical costs of treating breast cancer among younger Medicaid beneficiaries by stage at diagnosis.
Trogdon JG; Ekwueme DU; Poehler D; Thomas CC; Reeder-Hayes K; Allaire BT
Breast Cancer Res Treat; 2017 Nov; 166(1):207-215. PubMed ID: 28702893
[TBL] [Abstract][Full Text] [Related]
4. Association between medical home enrollment and health care utilization and costs among breast cancer patients in a state Medicaid program.
Kohler RE; Goyal RK; Lich KH; Domino ME; Wheeler SB
Cancer; 2015 Nov; 121(22):3975-81. PubMed ID: 26287506
[TBL] [Abstract][Full Text] [Related]
5. Value Analysis of Digital Breast Tomosynthesis for Breast Cancer Screening in a US Medicaid Population.
Miller JD; Bonafede MM; Herschorn SD; Pohlman SK; Troeger KA; Fajardo LL
J Am Coll Radiol; 2017 Apr; 14(4):467-474.e5. PubMed ID: 28139412
[TBL] [Abstract][Full Text] [Related]
6. Treatment Costs of Breast Cancer Among Younger Women Aged 19-44 Years Enrolled in Medicaid.
Ekwueme DU; Allaire BT; Guy GP; Arnold S; Trogdon JG
Am J Prev Med; 2016 Feb; 50(2):278-85. PubMed ID: 26775907
[TBL] [Abstract][Full Text] [Related]
7. Return on Investment Analysis of Breast Cancer Screening and Downstaging in Egypt: Implications for Developing Countries.
Skrundevskiy AN; Omar OS; Kim J; Soliman AS; Korolchuk TA; Wilson FA
Value Health Reg Issues; 2018 Sep; 16():22-27. PubMed ID: 29626738
[TBL] [Abstract][Full Text] [Related]
8. Role of Medicaid in Early Detection of Screening-Amenable Cancers.
Bradley CJ; Sabik LM; Entwistle J; Stevens JL; Enewold L; Warren JL
Cancer Epidemiol Biomarkers Prev; 2022 Jun; 31(6):1202-1208. PubMed ID: 35322273
[TBL] [Abstract][Full Text] [Related]
9. The Breast and Cervical Cancer Early Detection Program, Medicaid, and breast cancer outcomes among Ohio's underserved women.
Koroukian SM; Bakaki PM; Htoo PT; Han X; Schluchter M; Owusu C; Cooper GS; Rose J; Flocke SA
Cancer; 2017 Aug; 123(16):3097-3106. PubMed ID: 28542870
[TBL] [Abstract][Full Text] [Related]
10. Medicaid savings from the Contraceptive CHOICE Project: a cost-savings analysis.
Madden T; Barker AR; Huntzberry K; Secura GM; Peipert JF; McBride TD
Am J Obstet Gynecol; 2018 Dec; 219(6):595.e1-595.e11. PubMed ID: 30194049
[TBL] [Abstract][Full Text] [Related]
11. Long-term cost of breast cancer treatment to the United States Medicare Program by stage at diagnosis.
Grady I; Grady S; Chanisheva N
Eur J Health Econ; 2021 Dec; 22(9):1365-1370. PubMed ID: 34008086
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of a Medicaid expansion for cancer care: The Breast and Cervical Cancer Prevention and Treatment Act of 2000.
Lantz PM; Soliman S
Womens Health Issues; 2009; 19(4):221-31. PubMed ID: 19589471
[TBL] [Abstract][Full Text] [Related]
13. Economic and utilization outcomes of medication management at a large Medicaid plan with disease management pharmacists using a novel artificial intelligence platform from 2018 to 2019: a retrospective observational study using regression methods.
Kessler S; Desai M; McConnell W; Jai EM; Mebine P; Nguyen J; Kiroyan C; Ho D; Von Schweber E; Von Schweber L
J Manag Care Spec Pharm; 2021 Sep; 27(9):1186-1196. PubMed ID: 34032130
[No Abstract] [Full Text] [Related]
14. Prevalence, healthcare utilization, and costs of breast cancer in a state Medicaid fee-for-service program.
Khanna R; Madhavan SS; Bhanegaonkar A; Remick SC
J Womens Health (Larchmt); 2011 May; 20(5):739-47. PubMed ID: 21417935
[TBL] [Abstract][Full Text] [Related]
15. Comparing Breast Cancer Outcomes Between Medicaid and the Ohio Breast and Cervical Cancer Early Detection Program.
Koroukian SM; Bakaki PM; Schluchter M; Owusu C; Cooper GS; Flocke SA
J Oncol Pract; 2015 Nov; 11(6):478-85. PubMed ID: 26374859
[TBL] [Abstract][Full Text] [Related]
16. End-of-Life Medical Costs of Medicaid Cancer Patients.
Tangka FK; Subramanian S; Sabatino SA; Howard DH; Haber S; Hoover S; Richardson LC
Health Serv Res; 2015 Jun; 50(3):690-709. PubMed ID: 25424134
[TBL] [Abstract][Full Text] [Related]
17. Cost analysis of the National Breast and Cervical Cancer Early Detection Program: selected states, 2003 to 2004.
Ekwueme DU; Gardner JG; Subramanian S; Tangka FK; Bapat B; Richardson LC
Cancer; 2008 Feb; 112(3):626-35. PubMed ID: 18157831
[TBL] [Abstract][Full Text] [Related]
18. Cost and utilization of behavioral health medications associated with rescission of an exemption for prior authorization for severe and persistent mental illness in the Vermont Medicaid Program.
Simeone JC; Marcoux RM; Quilliam BJ
J Manag Care Pharm; 2010 Jun; 16(5):317-28. PubMed ID: 20518584
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of specialized medication packaging combined with medication therapy management: adherence, outcomes, and costs among Medicaid patients.
Zillich AJ; Jaynes HA; Snyder ME; Harrison J; Hudmon KS; de Moor C; French DD
Med Care; 2012 Jun; 50(6):485-93. PubMed ID: 22498687
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
